161

Public Health & Prevention
Focuses on global human health and epidemic prevention.
Sub Categories on Public Health & Prevention
Latest Articles
Study affirms benefit of very early antiretroviral therapy within hours of birth for newborns with HIV

Study affirms benefit of very early antiretroviral therapy within hours of birth for newborns with HIV

by Johns Hopkins University School of MedicineCredit: Pixabay/CC0 Public DomainA study of more than 50 babies in Africa, Asia, North America and South America has added substantially to evidence

Study affirms benefit of very early antiretroviral therapy within hours of birth for newborns with HIV

by Johns Hopkins University School of MedicineCredit: Pixabay/CC0 Public DomainA study of more than 50 babies in Africa, Asia, North America and South America has added substantially to evidence
How SARS-CoV-2 hijacks human cells to evade immune system

How SARS-CoV-2 hijacks human cells to evade immune system

by University of California - San DiegoHuman enzyme METTL3 adds methyl groups to introduce m6A in SARS-CoV-2’s RNA. That modification prevents the virus’ RNA from triggering inflammatory molecule

How SARS-CoV-2 hijacks human cells to evade immune system

by University of California - San DiegoHuman enzyme METTL3 adds methyl groups to introduce m6A in SARS-CoV-2’s RNA. That modification prevents the virus’ RNA from triggering inflammatory molecule
SARS-CoV-2 variants, including mutated variants resembling omicron, are evolving new ways to evade antibodies, vaccines

SARS-CoV-2 variants, including mutated variants resembling omicron, are evolving new ways to evade antibodies, vaccines

by Jake Miller,Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainIn an effort to predict future evolutionary maneuvers of SARS-CoV-2, a research team led by investigators at Harvard Medical

SARS-CoV-2 variants, including mutated variants resembling omicron, are evolving new ways to evade antibodies, vaccines

by Jake Miller,Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainIn an effort to predict future evolutionary maneuvers of SARS-CoV-2, a research team led by investigators at Harvard Medical
SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune
SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

by Heinrich-Heine University DuesseldorfThe coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the hum

SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

by Heinrich-Heine University DuesseldorfThe coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the hum
SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base
SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesGraphical representation of T cell recognizing and killing SARS-CoV-2 infected cell (top). Mutant SARS-CoV-2 is not pr

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesGraphical representation of T cell recognizing and killing SARS-CoV-2 infected cell (top). Mutant SARS-CoV-2 is not pr
How SARS-CoV-2 evades the immune system

How SARS-CoV-2 evades the immune system

by Hokkaido UniversityThe expression of the immune response gene NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Koichi Kobayashi). Credit: Koichi KobayashiResearche

How SARS-CoV-2 evades the immune system

by Hokkaido UniversityThe expression of the immune response gene NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Koichi Kobayashi). Credit: Koichi KobayashiResearche
SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator
Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

by University of BirminghamCredit: Pixabay/CC0 Public DomainPatients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the g

Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection

by University of BirminghamCredit: Pixabay/CC0 Public DomainPatients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the g
SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

by Kelley Luckstein,Mayo ClinicThis is an illustration of a SARS-CoV-2 particle, top left. To the right of the particle, the viral genome is stretched out. Genes are represented by boxes of diff

SARS-CoV-2 mutations come and go, and physicians' advice remains the same: Please vaccinate

by Kelley Luckstein,Mayo ClinicThis is an illustration of a SARS-CoV-2 particle, top left. To the right of the particle, the viral genome is stretched out. Genes are represented by boxes of diff
Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

by Barcelona Institute for Global HealthColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captu

Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection

by Barcelona Institute for Global HealthColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captu